Douglas Forsyth

Director at Inhibrx Biosciences · 1 reported transaction in 1 company · latest trade Sep 8, 2026

Their record

No purchases old enough to measure yet.


Inhibrx BiosciencesINBX	Bought $286.6K · 2,500 shares	Sep 8, 2026	S&P 500 +0.8%thru Oct 29

Sep 8, 2026 · INBX

$286.6K

S&P 500 +0.8%thru Oct 29

1 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

Director at Inhibrx Biosciences · 1 reported transaction in 1 company · latest trade Sep 8, 2026

No purchases old enough to measure yet.


Inhibrx BiosciencesINBX	Bought $286.6K · 2,500 shares	Sep 8, 2026	S&P 500 +0.8%thru Oct 29

Sep 8, 2026 · INBX

$286.6K

S&P 500 +0.8%thru Oct 29

1 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.